Boehringer Ingelheim, founded in 1885, is one of the world's top 20 pharmaceutical companies. It is headquartered in Ingelheim, Germany, and operates globally with around 51,000 employees as of 2023.

The family-owned company is committed to researching, developing, manufacturing, and marketing innovative medicines for both human and veterinary health. In 2022, Boehringer Ingelheim reported revenues of approximately €19.57 billion, showcasing a steady financial performance.